SITC Resource Library

Back to Library

Research News: FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) combination for MSI-H/dMMR Metastatic Colorectal Cancer Patients 

07-26-2018 09:43

Posted on the Fight Colorectal Cancer blog is an article about the latest FDA approved immunotherapy treatment MSI-H/dMMR Metastatic Colorectal cancer patients.

Click here to read the latest FDA update.


#ColorectalCancer #Journalarticle #CollaborativePartner #CombinationTherapy #ImmuneCheckpointInhibitors 
#Nivolumab #Ipilimumab #Biomarkers #RegisteredNurse #Patient #PatientAdvocate
#FightColorectalCancer(FCC)

Click here to read "Research News: FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) combination for MSI-H/dMMR Metastatic Colorectal Cancer Patients "
Statistics
0 Favorited
16 Views
0 Files
0 Shares
0 Downloads

Related Entries and Links

No Related Resource entered.